Literature DB >> 23860447

Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients.

S Weissmann1, A Roller, S Jeromin, M Hernández, M Abáigar, J M Hernández-Rivas, V Grossmann, C Haferlach, W Kern, T Haferlach, S Schnittger, A Kohlmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23860447     DOI： 10.1038/leu.2013.218

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  25 in total

1.  SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

Authors:  S Jeromin; S Weissmann; C Haferlach; F Dicker; K Bayer; V Grossmann; T Alpermann; A Roller; A Kohlmann; T Haferlach; W Kern; S Schnittger
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

2.  A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia.

Authors:  P Sportoletti; S Baldoni; B Del Papa; P Aureli; E Dorillo; L Ruggeri; S Plebani; V Amico; A Di Tommaso; E Rosati; P Marconi; M Di Ianni; F Falzetti
Journal:  Leukemia       Date:  2013-10-09       Impact factor: 11.528

Review 3.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 4.  Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

Review 5.  Molecular pathogenesis of CLL and its evolution.

Authors:  David Rodríguez; Gabriel Bretones; Javier R Arango; Víctor Valdespino; Elías Campo; Víctor Quesada; Carlos López-Otín
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

Review 6.  Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.

Authors:  Mohammad Shahjahani; Javad Mohammadiasl; Fatemeh Noroozi; Mohammad Seghatoleslami; Saeid Shahrabi; Fakhredin Saba; Najmaldin Saki
Journal:  Cell Oncol (Dordr)       Date:  2015-01-07       Impact factor: 6.730

7.  EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.

Authors:  Rajeswara Rao Arasada; Joseph M Amann; Mohammad A Rahman; Stacey S Huppert; David P Carbone
Journal:  Cancer Res       Date:  2014-08-14       Impact factor: 12.701

Review 8.  Evolving understanding of the CLL genome.

Authors:  Michaela Gruber; Catherine J Wu
Journal:  Semin Hematol       Date:  2014-05-15       Impact factor: 3.851

Review 9.  Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.

Authors:  Richard Rosenquist; Andreas Rosenwald; Ming-Qing Du; Gianluca Gaidano; Patricia Groenen; Andrew Wotherspoon; Paolo Ghia; Philippe Gaulard; Elias Campo; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

Review 10.  The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Authors:  Gianluca Gaidano; Davide Rossi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.